Signature Wealth Management Partners’s Gilead Sciences GILD Stock Holding History

Signature Wealth Management Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,864	Closed	-$221K	–	97
2023 Q2	$221K	Hold	2,864	–	–	0.2%	89
2023 Q1	$238K	Sell	2,864 -1,000	-26%	-$82.8K	0.22%	87
2022 Q4	$332K	Hold	3,864	–	–	0.33%	70
2022 Q3	$238K	Hold	3,864	–	–	0.26%	82
2022 Q2	$239K	Sell	3,864 -251	-6%	-$15.5K	0.24%	85
2022 Q1	$245K	Hold	4,115	–	–	0.21%	93
2021 Q4	$299K	Sell	4,115 -600	-13%	-$41.3K	0.25%	85
2021 Q3	$329K	Hold	4,715	–	–	0.3%	75
2021 Q2	$325K	Sell	4,715 -200	-4%	-$13.4K	0.3%	78
2021 Q1	$318K	Buy	4,915 +1,000	+26%	+$64.5K	0.31%	75
2020 Q4	$228K	Buy	+3,915	New	+$236K	0.23%	85

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Signature Wealth Management Partners's GILD Position: Q3 2023 in Review

Signature Wealth Management Partners sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 2,864 shares — an estimated $221K sold.

Signature Wealth Management Partners first reported a position in GILD in Q4 2020 and held it in 11 quarters. The position peaked at $332K in Q4 2022. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Signature Wealth Management Partners reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Signature Wealth Management Partners sold 2,864 Gilead Sciences shares in Q3 2023, an estimated $221K.
Signature Wealth Management Partners first reported a position in Gilead Sciences in Q4 2020 and held it in 11 quarters.
Signature Wealth Management Partners's Gilead Sciences position peaked at $332K in Q4 2022.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Signature Wealth Management Partners's 13F filing for Q3 2023, filed 24 Oct 2023.